Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?
Ava L. Liberman(Cornell University), Shyam Prabhakaran(Los Angeles Medical Center), Fan Z. Caprio(Northwestern University), Matthew B. Maas(Northwestern University), Richard A. Bernstein(Northwestern University), Rahul K. Khare(Northwestern University), Eric M. Liotta(Northwestern University), Deborah Bergman(Northwestern University), Ilana Ruff
Cited by 56
Related Papers
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke
|Stroke|2013|1.7k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823